Ireland-based Medtronic plc, a $28.9b maker of cardiac, vascular, diabetes, restorative therapy and minimally invasive devices. is buying Companion Medical, a developer of a “smart” insulin pens and accompanying mobile apps for personalized diabetes management.  The deal adds an FDA-cleared, first-of-its kind “smart” insulin device, InPen, to Medtronic’s diabetes offerings. InPen tracks patient insulin dose data, monitors active insulin, recommends …

Teladoc (NYSE: TDOC), a $553.3m telemedicine provider, is buying Livongo (Nasdaq: LVGO), a $170.2m digital health and virtual diabetes coaching company, in an $18.5b merger, to create a company with a combined $1.3b in revenue in 2020, up 85% YOY.  This is the largest digital health deal in history, ringing in at a purchase price for Livongo at $18.5b, and …

Creo Medical, a UK-based developer of endoscopic microwave and radiofrequency ablation technologies, is acquiring Albyn Medical, a Spain-based manufacturer of branded and third-party gastroenterology, urology and endoscopy products including biopsy forceps, snares, catheters, tubes and valves. The acquisition expands Creo’s GI product suite and provides an entry into Urology. Deal value — $29.3m upfront plus an additional $3.2m in milestones …

Nexelis, a Canada-based provider of advanced assay development and laboratory testing services in infectious, oncologic, and metabolic diseases and an Ampersand Capital Partners portfolio company, has acquired AIT Bioscience, LLC, a U.S.-based integrated bioanalytical laboratory with liquid chromatography–mass spectrometry (LC-MS) and immunoassay testing capabilities.  The acquisition expands Nexelis’ geographic customer reach and supports its expertise in servicing the bioanalytical segment, …

Medtronic plc, a major, $28.9b medical device maker of cardiovascular, orthopedic, spinal and other surgical devices, is buying Medicrea, a France-based developer of patient-specific, 3D-printed titanium spinal implants and related workflow software that helps surgeons use predictive modeling to digitally reconstruct a patient’s spine profile. The deal complements Medtronic’s recent $1.6b acquisition of robotic spinal surgery guidance system developer Mazor …

UK-based producer of diagnostic reagents LGC has purchased The Native Antigen Company (NAC), a UK-based supplier of recombinant viral and bacterial antigens, antibodies and immunoassays. NAC was among the first companies to offer antigens for SARS-COV-2 on a global scale.  The deal adds >60 viral and infectious disease products to LGC’s existing portfolio of assurance tools, immunoassays and probes and primers for molecular diagnostics.  Terms not announced. …

Teladoc Health, Inc. (NYSE: TDOC), a $553.3m provider of virtual healthcare services purchased InTouch Health, a producer of telehealth software and devices including tablets, remote monitoring systems and portable carts that mount HDMI-enabled televisions or monitors for physicians to view patients during telehealth appointments.  The acquisition helps Teladoc scale and enable hospitals and physician practices to virtualize amid the seismic …

LeMaitre Vascular, a $117.2m maker of specialized catheters, shunts and grafts to treat peripheral vascular disease has acquired Artegraft, Inc., a developer of bovine carotid artery-derived biologic grafts used to treat hemodialysis access patients, for $72.5m upfront and milestones of up to $17.5m.  Artegraft’s sales grew 10% in 2019.  During the trailing 12 months ended 5/31/20, Artegraft generated trade sales …

iSchemaView Inc. d/b/a/ RapidAI, a developer of an advanced cerebrovascular imaging platform, purchased EndoVantage, producer of the “Find, Track and Treat” cerebral aneurysm management platform.  The deal provides RapidAI with the capability to automate the entire cerebral aneurysm and stroke workflow from initial assessment, to growth monitoring, to treatment planning.  EndoVantage’s platform, initially developed at the Mayo Clinic and Arizona State University, uses computed …

UK-based orthotics and prosthetics producer Steeper Group has acquired College Park Industries’ Espire elbow prostheses range.  The Espire range includes five mechanical elbow models with prosthetic elbow joint control enabling patients to perform everyday weight-bearing activities.  The acquisition builds on Steeper’s upper limb product portfolio and U.S. market penetration.  The deal followed Iceland-based Össur’s acquisition of College Park Industries, which …